Alterations of the redox state, pentose pathway and glutathione metabolism in an acute porphyria model. their impact on heme pathway
A classical acute porphyria model in rats consists of combined treatment with 2-allyl-2-isopropylacetamide (AIA) and 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC). The present work describes the effects of this treatment on the pentose phosphate (PP) pathway, glutahione metabolism and redox state...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
2013
|
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 17016caa a22016217a 4500 | ||
|---|---|---|---|
| 001 | PAPER-24341 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230518205610.0 | ||
| 008 | 190411s2013 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-84877661190 | |
| 024 | 7 | |2 cas |a 5 aminolevulinate synthase, 9037-14-3; glucose, 50-99-7, 84778-64-3; glucose 6 phosphate dehydrogenase, 37259-83-9, 9001-40-5; glutathione, 70-18-8; glutathione disulfide, 27025-41-8; glutathione peroxidase, 9013-66-5; glutathione reductase, 9001-48-3; glutathione transferase, 50812-37-8; heme, 14875-96-8; phosphogluconate dehydrogenase, 9001-82-5; 3,5-diethoxycarbonyl-1,4-dihydrocollidine; Allylisopropylacetamide, 299-78-5; Glucose, 50-99-7; Glucosephosphate Dehydrogenase, 1.1.1.49; Glutathione, 70-18-8; Glutathione Disulfide, 27025-41-8; Glutathione Peroxidase, 1.11.1.9; Glutathione Reductase, 1.8.1.7; Glutathione Transferase, 2.5.1.18; Heme, 14875-96-8; NADP, 53-59-8; Pyridines; Reactive Oxygen Species | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 030 | |a EBMMB | ||
| 100 | 1 | |a Faut, M. | |
| 245 | 1 | 0 | |a Alterations of the redox state, pentose pathway and glutathione metabolism in an acute porphyria model. their impact on heme pathway |
| 260 | |c 2013 | ||
| 270 | 1 | 0 | |m Mazzetti, M. B.; Laboratorio de Disturbios Metabólicos por Xenobióticos, Salud Humana y Medio Ambiente, Departamento de Química Biológica, Universidad de Buenos Aires, Ciudad Universitaria, Pab. II, 4to Piso, Ciudad Autónoma de Buenos Aires, C1428EGA, Argentina; email: mazzetti@qb.fcen.uba.ar |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Kappas, A., Sassa, S., Galbraith, R.A., Nordmann, Y., The porphyries (1995) Metabolic and Molecular Basis of Inherited Disease, pp. 2103-2159. , In: Scriver CR, Beaudet AL, Sly WS, et al., eds., New York: McGraw-Hill | ||
| 504 | |a Smith, A.G., de Matteis, F., Drugs and the hepatic porphyrias (1980) Clin Haematol, 9, pp. 399-425 | ||
| 504 | |a Marks, G.S., McCluskey, S.A., Mackie, J.E., Riddick, D.S., James, C.A., Disruption of hepatic heme biosynthesis after interaction of xenobiotics with cytochrome P-450 (1988) FASEB J, 2, pp. 2774-2783 | ||
| 504 | |a Lelli, S.M., San Martin de Viale, L.C., Mazzetti, M.B., Response of glucose metabolism enzymes in an acute porphyria model (2005) Role of Reactive Oxygen Species. Toxicology, 216, pp. 49-58 | ||
| 504 | |a Rocha, M.E., Dutra, F., Bandy, B., Baldini, R.L., Gomes, S.L., Faljoni-Alario, A., Liria, C.W., Bechara, E.J., Oxidative damage to ferritin by 5-aminolevulinic acid (2003) Arch Biochem Biophys, 409, pp. 349-356 | ||
| 504 | |a Monteiro, H.P., Abdalla, D.S.P., Augusto, O., Bechara, E.J.H., Free radical generation during delta-aminolevulinic acid autoxidation: Induction by hemoglobin and connections with porphyrinpathies (1989) Arch Biochem Biophys, 271, pp. 206-216 | ||
| 504 | |a Halliwell, B., Gutteridge, J.M.C., (1999) Free Radicals In Biology and Medicine, pp. 450-622. , 3rd edn. London: Oxford University Press | ||
| 504 | |a Rose, J.A., Hellman, E.S., Tschudy, D.P., Effect on diet on induction of experimental porphyria (1961) Metabolism, 10, pp. 514-521 | ||
| 504 | |a Tschudy, D.P., Welland, F.H., Collins, A., Hunter Jr., G., The effect of carbohydrate feeding on the induction of delta-aminolevulinic acid synthetase (1964) Metabolism, 13, pp. 396-406 | ||
| 504 | |a Matkovic, L.B., D'andrea, F., Fornes, D., San Martín de Viale, L.C., Mazzetti, M.B., How porphyrinogenic drugs modeling acute porphyria impair the hormonal status that regulates glucose metabolism (2011) Their relevance in the onset of this disease Toxicology, 290, pp. 22-30 | ||
| 504 | |a Berg, J.M., Stryer, L., Tymoczko, J.L., (2007) Biochemistry, , 6th edn. New York: Freeman and Co | ||
| 504 | |a Spolarics, Z., Endotoxemia, pentose cycle, and the oxidant/antioxidant balance in the hepatic sinusoid (1998) J Leukoc Biol, 63, pp. 534-541 | ||
| 504 | |a Pompella, A., Visvikis, A., Paolicchi, A., de Tata, V., Casini, A.F., The changing faces of glutathione, a cellular protagonist (2003) Biochem Pharmacol, 66, pp. 1499-1503 | ||
| 504 | |a Pastore, A., Piemonte, F., Locatelli, M., Lo Russo, A., Gaeta, L.M., Tozzi, G., Federici, G., Determination of blood total, reduced, and oxidized glutathione in pediatric subjects (2001) Clin Chem, 47, pp. 1467-1469 | ||
| 504 | |a Hayes, J.D., Pulford, D.J., The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance (1995) Crit Rev Biochem Mol Biol, 30, pp. 445-600 | ||
| 504 | |a Higgins, L.G., Hayes, J.D., Mechanisms of induction of cytosolic and microsomal glutathione transferase (GST) genes by xenobiotics and pro-inflammatory agents (2011) Drug Metab Rev, 43, pp. 92-137 | ||
| 504 | |a Ahmad, H., Singh, S., Awasthi, Y.C., Inhibition of bovine lens glutathione S-transferases by hematin, bilirubin, and bromosulfophthalein (1991) Lens Eye Toxic Res, 8, pp. 431-440 | ||
| 504 | |a Aniya, Y., Anders, M.W., Alteration of hepatic glutathione S-transferases and release into serum after treatment with bromobenzene, carbon tetrachloride, or N-nitrosodimethylamine (1985) Biochem Pharmacol, 34, pp. 4239-4244 | ||
| 504 | |a de Matteis, F., Rapid loss of cytochrome P-450 and haem caused in the liver microsomes by the porphyrinogenic agent 2-allyl-2-isopropilacetamide (1970) FEBS Lett, 6, pp. 343-345 | ||
| 504 | |a de Matteis, F., Abbritti, G., Gibbs, A.H., Decreased liver activity of porphyrin-metal chelatase in hepatic porphyria caused by 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Studies in rats and mice (1973) Biochem J, 134, pp. 717-727 | ||
| 504 | |a Hift, R.J., Thunell, S., Brun, A., Drugs to porphyria: From observation to a modern algoritm-based system for the prediction o porphyrinogenicity (2011) Pharmacol and Therap, 132, pp. 158-169 | ||
| 504 | |a Marver, H.S., Tscudy, D.P., Perlroth, M.J., Collins, A., Deltaaminolevulinic acid synthetase. I. Studies in liver homogenates (1966) J Biol Chem, 241, pp. 2803-2809 | ||
| 504 | |a Mauzerall, D., Granick, S., The occurrence and determination of 5-aminolevulinic acid and porphobilinogen in urine (1956) J Biol Chem, 219, pp. 435-446 | ||
| 504 | |a Foucaud, L., Goulaouic, S., Bennasroune, A., Laval-Gilly, P., Brown, D., Stone, V., Falla, J., Oxidative stress induction by nanoparticles in THP-1 cells with 4-HNE production: Stress biomarker or oxidative stress signalling molecule? (2010) Toxicol In Vitro, 24, pp. 1512-1520 | ||
| 504 | |a Cathcart, R., Schwiers, E., Ames, B.N., Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay (1983) Anal Biochem, 134, pp. 111-116 | ||
| 504 | |a Mohandas, J., Marshall, J.J., Duggin, G.G., Horvath, J.S., Tiller, D.J., Low activities of glutathione-related enzymes as factors in the genesis of urinary bladder cancer (1984) Cancer Res, 44, pp. 5086-5091 | ||
| 504 | |a Haque, R., Bin-Hafeez, B., Parvez, S., Pandey, S., Sayeed, I., Ali, M., Raisuddin, S., Aqueous extract of walnut (Juglans regia L.), protects mice against cyclophosphamide-induced biochemical toxicity (2003) Hum Exp Toxicol, 22, pp. 473-480 | ||
| 504 | |a Sedlak, J., Lindsay, R.H., Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent (1968) Anal Biochem, 25, pp. 192-205 | ||
| 504 | |a Tietze, F., Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues (1969) Anal Biochem, 27, pp. 502-522 | ||
| 504 | |a Anderson, M.E., Determination of glutathione and glutathione disulfide in biological samples (1985) Meth Enzymol, 113, pp. 548-554 | ||
| 504 | |a Bottomley, R.H., Pitot, H.C., Potter, V.R., Morris, H.P., Metabolic adaptations in rat hepatomas: V. Reciprocal relationship between threonine dehydrase and glucose-6-phosphate dehydrogenase (1963) Cancer Res, 23, pp. 400-409 | ||
| 504 | |a Zhang, Z., Yu, J., Stanton, R.C., A method for determination of pyridine nucleotides using a single extract (2000) Anal Biochem, 285, pp. 163-167 | ||
| 504 | |a Lowry, H.O., Rosebrough, R.J., Farr, A.L., Randall, R.J., Protein measurement with the Folin phenol reagent (1995) J Biol Chem, 193, pp. 265-275 | ||
| 504 | |a Lowry, O.H., Passonneau, J.V., (1972) A Flexible System of Enzymatic Analysis, , New York: Academic Press | ||
| 504 | |a Motulsky, H., (2005) GraphPad Prism, , Version 4.0. Statistcs Guide. Statistical Analysis for Laboratory and Clinical Researchers. San Diego, CA, USA: GraphPad Software Inc | ||
| 504 | |a Bechara, E.J., A free hypothesis of porphyria with 5-aminolevulinic acid overload (1995) The Oxygen Paradox, pp. 503-513. , In: Davies KJA, Ursini F, eds., Italy: CLEUP University Press | ||
| 504 | |a Untucht-Grau, R., Schirmer, R.H., Schirmer, I., Krauth-Siegel, R.L., Glutathione reductase from human erythrocytes: Amino-acid sequence of the structurally known FAD-binding domain (1981) Eur J Biochem, 120, pp. 407-419 | ||
| 504 | |a Gutierrez-Correa, J., Stoppani, A.O., Inactivation of yeast glutathione reductase by Fenton systems: Effect of metal chelators, catecholamines and thiol compounds (1997) Free Radic Res, 27, pp. 543-555 | ||
| 504 | |a Morgenstern, R., Zhang, J., Johansson, K., Microsomal glutathione transferase 1: Mechanism and functional roles (2001) Drug Metab Rev, 43, pp. 300-306 | ||
| 504 | |a van Ommen, B., Ploemen, J.H., Ruven, H.J., Vos, R.M., Bogaards, J.J., van Berkel, W.J., van Bladeren, P.J., Studies on the active site of rat glutathione S-transferase isoenzyme 4-4. Chemical modification by tetrachloro-1,4-benzoquinone and its glutathione conjugate (1989) Eur J Biochem, 181, pp. 423-429 | ||
| 504 | |a Johnson, J.A., Finn, K.A., Siegel, F.L., Tissue distribution of enzymic methylation of glutathione S-transferase and its effects on catalytic activity. Methylation of glutathione S-transferase 11-11 inhibits conjugating activity towards 1-chloro-2, 4-dinitrobenzene (1992) Biochem J, 282, pp. 279-289 | ||
| 504 | |a van Bladeren, P.J., van Ommen, B., The inhibition of glutathione S-transferases: Mechanisms, toxic consequences and therapeutic benefits (1991) Pharmacol Ther, 51, pp. 35-46 | ||
| 504 | |a Joron, G.E., Downing, J.B., Bensley, E.H., Poisoning by Sedormid (allyl-isopropyl-acetyl urea) (1953) Can Med Assoc J, 68, pp. 62-63 | ||
| 504 | |a Moore, M.R., An historical introduction to porphyrin and chlorophyll synthesis (2009) Tetrapyrroles: Birth, Life and Death, pp. 1-28. , In: Warren MJ, Smith AG, eds., New York: Springer Sciences Business Media | ||
| 504 | |a Lelli, S.M., Mazzetti, M.B., San Martín de Viale, L.C., Hepatic alteration of tryptophan metabolism in an acute porphyria model its relation with gluconeogenic blockage (2008) Biochem Pharmacol, 75, pp. 704-712 | ||
| 504 | |a Raza, H., Dual localization of glutathione S-transferase in the cytosol and mitochondria: Implications in oxidative stress, toxicity and disease (2011) FEBS J, 278, pp. 4243-4251 | ||
| 504 | |a Kleiman de Pisarev, D.L., Ferramola de Sancovich, A.M., Sancovich, H.A., Hepatic indices of thyroid status in rats treated with hexachlorobenzene (1995) J Endocrinol Invest, 18, pp. 271-276 | ||
| 504 | |a Holzmann, H., Denk, R., Morsches, B., Fermenthestimmungen in erythrocytcn von kranken mit porphyria cutanea tarda (1969) Wien Klin Wschr, 47, pp. 112-114 | ||
| 504 | |a Rainer, H., Schnack, H., Moser, K., Untersuchungen üher den erythrozytcnstoffwechscl hei patienten mit porphyria hepatica (1970) Wien Klin Wschr, 82, pp. 853-865 | ||
| 504 | |a Markkanen, T., Peltola, O., Koskelo, P., Pentose phosphate metabolism of erythrocytes in hepaticporphyrias (1971) Acta Haematol, 46, pp. 142-148 | ||
| 520 | 3 | |a A classical acute porphyria model in rats consists of combined treatment with 2-allyl-2-isopropylacetamide (AIA) and 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC). The present work describes the effects of this treatment on the pentose phosphate (PP) pathway, glutahione metabolism and redox state and how they contribute to alter the glucose pool of hepatocytes and modulate porphyria, in Wistar rat livers. Our approach is based on the fact that glucose is a repressor of 5-aminolevulinic synthase (ALA-S), the rate-limiting enzyme of the heme pathway, and treatment with AIA/DCC causes oxidative stress. Different doses of the xenobiotcs were used. The results show that AIA (500 mg/kg body weight [BW])/ DDC (50 mg/kg [BW]) treatment increased glutathione peroxidase (GPx) activity by 46%, decreased both glutathione reductase (GR) and glutathione S-transferase (GST) activity by 69% and 52%, respectively, and reduced by 51% reduced glutathione (GSH) and increased by 100% glutathione disulfide (GSSG) concentrations, therefore lowering by four-fold the GSH/GSSG ratio. The activity of glucose-6-phosphate dehydrogenase (G6PD), the rate-limiting enzyme of PP-pathway, was increased by 129% as well as that of 6-phosphogluconate dehydrogenase. NADPH and the NADPH/NADP+ ratio were increased by 14% and 28%, respectively. These effects could be attributed to the generation of reactive oxygen species (ROS) elicited by the porphyrinogenic treatment, shown by enhanced DNA damage and ROS production. G6PD stimulation would decrease hepatic glucose concentrations and consequently exacerbate the porphyria. A decrease in glucose could stimulate ALA-S and this would add to the effect of drug-induced heme depletion. Since the key role of GST is to inactivate toxic compounds, the drastic fall in its activity together with the accumulation of ALA would account for the symptoms of this hepatic disease model. The present findings show the high metabolic interplay between pathways and constitute a relevant contribution to achieve a better treatment of acute human porphyria. © 2013 by the Society for Experimental Biology and Medicine. |l eng | |
| 593 | |a Laboratorio de Disturbios Metabólicos por Xenobióticos, Salud Humana y Medio Ambiente, Departamento de Química Biológica, Universidad de Buenos Aires, Ciudad Universitaria, Pab. II, 4to Piso, Ciudad Autónoma de Buenos Aires, C1428EGA, Argentina | ||
| 690 | 1 | 0 | |a GLUCOSE-6-PHOSPHATE DEHYDROGENASE |
| 690 | 1 | 0 | |a GLUTATHIONE METABOLISM |
| 690 | 1 | 0 | |a PENTOSE PHOSPHATE PATHWAY |
| 690 | 1 | 0 | |a PORPHYRIA |
| 690 | 1 | 0 | |a RAT LIVER |
| 690 | 1 | 0 | |a REACTIVE OXYGEN SPECIES |
| 690 | 1 | 0 | |a 5 AMINOLEVULINATE SYNTHASE |
| 690 | 1 | 0 | |a GLUCOSE |
| 690 | 1 | 0 | |a GLUCOSE 6 PHOSPHATE DEHYDROGENASE |
| 690 | 1 | 0 | |a GLUTATHIONE |
| 690 | 1 | 0 | |a GLUTATHIONE DISULFIDE |
| 690 | 1 | 0 | |a GLUTATHIONE PEROXIDASE |
| 690 | 1 | 0 | |a GLUTATHIONE REDUCTASE |
| 690 | 1 | 0 | |a GLUTATHIONE TRANSFERASE |
| 690 | 1 | 0 | |a HEME |
| 690 | 1 | 0 | |a PHOSPHOGLUCONATE DEHYDROGENASE |
| 690 | 1 | 0 | |a PYRIDINE NUCLEOTIDE |
| 690 | 1 | 0 | |a REACTIVE OXYGEN METABOLITE |
| 690 | 1 | 0 | |a ACUTE INTERMITTENT PORPHYRIA |
| 690 | 1 | 0 | |a ANIMAL EXPERIMENT |
| 690 | 1 | 0 | |a ANIMAL MODEL |
| 690 | 1 | 0 | |a ANIMAL TISSUE |
| 690 | 1 | 0 | |a ARTICLE |
| 690 | 1 | 0 | |a BLOOD SAMPLING |
| 690 | 1 | 0 | |a CONTROLLED STUDY |
| 690 | 1 | 0 | |a DNA DAMAGE |
| 690 | 1 | 0 | |a ENZYME LINKED IMMUNOSORBENT ASSAY |
| 690 | 1 | 0 | |a FEMALE |
| 690 | 1 | 0 | |a GLUTATHIONE METABOLISM |
| 690 | 1 | 0 | |a NONHUMAN |
| 690 | 1 | 0 | |a OXIDATION REDUCTION STATE |
| 690 | 1 | 0 | |a OXIDATIVE STRESS |
| 690 | 1 | 0 | |a PENTOSE PHOSPHATE CYCLE |
| 690 | 1 | 0 | |a PROTEIN DETERMINATION |
| 690 | 1 | 0 | |a RAT |
| 690 | 1 | 0 | |a SPECTROPHOTOMETRY |
| 690 | 1 | 0 | |a URINALYSIS |
| 690 | 1 | 0 | |a ALLYLISOPROPYLACETAMIDE |
| 690 | 1 | 0 | |a ANIMALS |
| 690 | 1 | 0 | |a DISEASE MODELS, ANIMAL |
| 690 | 1 | 0 | |a GLUCOSE |
| 690 | 1 | 0 | |a GLUCOSEPHOSPHATE DEHYDROGENASE |
| 690 | 1 | 0 | |a GLUTATHIONE |
| 690 | 1 | 0 | |a GLUTATHIONE DISULFIDE |
| 690 | 1 | 0 | |a GLUTATHIONE PEROXIDASE |
| 690 | 1 | 0 | |a GLUTATHIONE REDUCTASE |
| 690 | 1 | 0 | |a GLUTATHIONE TRANSFERASE |
| 690 | 1 | 0 | |a HEME |
| 690 | 1 | 0 | |a LIVER |
| 690 | 1 | 0 | |a NADP |
| 690 | 1 | 0 | |a OXIDATION-REDUCTION |
| 690 | 1 | 0 | |a OXIDATIVE STRESS |
| 690 | 1 | 0 | |a PENTOSE PHOSPHATE PATHWAY |
| 690 | 1 | 0 | |a PORPHYRIA, ACUTE INTERMITTENT |
| 690 | 1 | 0 | |a PYRIDINES |
| 690 | 1 | 0 | |a RATS |
| 690 | 1 | 0 | |a REACTIVE OXYGEN SPECIES |
| 700 | 1 | |a Paiz, A. | |
| 700 | 1 | |a de Viale, L.C.S.M. | |
| 700 | 1 | |a Mazzetti, M.B. | |
| 773 | 0 | |d 2013 |g v. 238 |h pp. 133-143 |k n. 2 |p Exp. Biol. Med. |x 15353702 |t Experimental Biology and Medicine | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-84877661190&doi=10.1177%2f1535370212473702&partnerID=40&md5=b58880843c67080609640e1fa786f15b |y Registro en Scopus |
| 856 | 4 | 0 | |u https://doi.org/10.1177/1535370212473702 |y DOI |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_15353702_v238_n2_p133_Faut |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_15353702_v238_n2_p133_Faut |y Registro en la Biblioteca Digital |
| 961 | |a paper_15353702_v238_n2_p133_Faut |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 999 | |c 85294 | ||